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On Anaplasma phagocytophilum in horses   
Abstract 
Equine Granulocytic Anaplasmosis (EGA) is an acute tick-borne infection 
caused by Anaplasma phagocytophilum. The bacterium can infect various 
animal species and humans. Persistence of infection is documented in 
ruminants and is shown experimentally in dogs, but it is unknown whether 
it occurs in horses or if EGA induces longer-term clinical changes in horses.     
This thesis includes results and analyses of a serosurvey of the exposure 
level and association with clinical disease (excluding acute EGA) in over 
2000 horses throughout Sweden. It also includes an experimental infection 
study of six horses using a Swedish isolate of the bacterium.           
Overall 17% of the horses were seropositive with large geographical 
variations. However, seropositivity was not statistically associated with any 
increase in clinical sign or disease in the animals.  
In the experimental study acute disease was readily induced and the 
clinical disease was similar to EGA described from USA. Laboratory data 
showed that the PCR test had the widest diagnostic window for EGA with 
positive signals days before onset of clinical signs. Clinically, diagnostic 
inclusions (morulae) in leukocytes in blood smears were visible first after a 
few days into clinical disease and lasted shorter time than did the PCR 
signal. 
One horse died suddenly 2 days into the acute disease, with post mortem 
changes of general vasculitis and hyaline thrombi in the kidneys suggesting 
disseminative intravascular coagulation (DIC). This was the first 
documented case of death attributed probably soley to EGA.  
The remaining horses were closely monitored for more than 3 months 
after spontaneous recovery from EGA. Some of the horses became 
transiently PCR positive during this period, mainly close in time after 
selected interventions to mimic stress. However no detectable clinical 
abnormalities were found during this follow-up period. At post mortem 
there were no macroscopic or microscopic changes in any of the tissues that 
could be associated with persistence of infection.  
In conclusion this thesis shows that for EGA; seropositive horses in 
Sweden are common but do not have increased levels of clinical disease; 
PCR provides the earliest laboratory diagnosis for acute EGA-infection;  
sudden death due to EGA can occur; and the organism can persist in some 
horses for up to 3 months post recovery but was clinically and 
pathologically silent. 
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  Introduction 
  Historical background 
Tick borne fever in domestic ruminants in Europe has been known for at 
least 200 years (Stuen 2007) though it was not until 1932 the disease was 
associated with actual tick infestation and the infective agent involved was 
assumed to be a Rickettsia (Gordon et al. 1932a, Gordon et al. 1932b, 
Gordon et al. 1940). The organism was classified as Rickettsia phagocytophila 
(Foggie 1951) and later named Ehrlichia phagocytophila in Bergeys manual of 
determinative bacteriology (Philip 1974). The genus Ehrlichia, within the 
family Rickettsiaceae was named to honour the German bacteriologist Paul 
Ehrlich. Ehrlichial organisms grow strictly intracellularly, with different 
target cells for different species of Ehrlichia.  Ehrlichia phagocytophila has 
predilection for granulocytic leukocytes, with aggregations of bacteria 
visible in the cytoplasm of neutrophils and occasionally in eosinophils on 
blood smears from infected animals. These form inclusion bodies also 
named “morulae”. The disease has also thus been named “granulocytic 
ehrlichiosis”. 
During the last 40 years granulocytic ehrlichiosis has subsequently been 
recognized in a number of other animal species. In the horse it was first 
described from California as a febrile disease with inclusion bodies 
detectable in the cytoplasm of granulocytes (Gribble 1969), and resembling 
the clinical disease in ruminants. The agent infecting horses was called 
Ehrlichia equi. 
Later a febrile disease with detectable morulae in granulocytes was 
recognized in dogs (Madevall and Gribble 1982, Bellström 1988). The first 
confirmed clinical case in cats was reported in 1999 (Bjöersdorff et al. 
1999). Further, a similar infection with clinical febrile disease and inclusion   12
bodies visible in neutrophilic granulocytes of febrile humans was also 
described (Bakken et al. 1994, Chen et al. 1994). The causative agent in 
humans was called “the human granulocytic ehrlichiosis-agent” - the HGE-
agent since it was not known if it was identical to E. phagocytophila or E. 
equi. The infection has also been recognized in the wild fauna, for example 
in rodents and roe-deer. Moreover, several other mammalian species have 
been shown to be both seropositive and PCR positive (Stuen 2007).  
  The bacterium Anaplasma phagocytophilum 
The genera Anaplasma, Ehrlichia, Cowdria, Neorickettsia and Wolbachia are 
all intracellular bacteria infecting eukaryotic cells. Historically they have 
been placed in taxa based on morphological epidemiological and clinical 
characteristics. The “Ehrlichia group” consisted of a number of bacteria 
infecting different species and gave rise to different diseases, apart from E. 
phagocytophila, E. equi and the HGE-agent, including Potomac horse fever 
in horses (Ehrlichia risticii - monocytic), monocytic senettsue fever in man 
(Ehrlichia senettsu), Ehrlichia ewingi causing (another) granulocytic ehrlichiosis 
in dogs and humans and Ehrlichia canis causing chronic monocytic infection 
in dogs (Table 1). Recent genetical analyses of 16S rRNA, groESL and 
surface protein genes have resulted in phylogenetic trees showing the 
genetic “relationship” among different genera. This has lead to a recent 
reorganization of taxonomy (Dumler et al. 2001) resulting in a new 
classification and new names for certain bacteria based on the genetic 
similarity (Table 1). In this new classification, Ehrlichia equi, Ehrlichia 
phagocytophila and the HGE-agent, were deemed to be so closely related 
genetically that they were amalgamated into the same and “new” species, 
named “Anaplasma phagocytophilum” (Dumler et al. 2001). The new species 
A. phagocytophilum is described as being a gram-negative coccoid to 
ellipsoidal, often pleomorphic bacterium. Two ultra-structural 
morphologies may occur; a larger reticulate form and a smaller dense form 
containing condensed protoplasm (Dumler et al. 2001). The bacterium is an 
obligate intracellular organism that infects predominantly blood cells, 
principally granulocytes and especially neutrophils (Rikihisa 1991). In the 
target cell, bacteria are internalised in separate phagosomes and avoid 
degradation by inhibiting the phagosome from fusing with lysosomes 
(Rikihisa 1991, Carlyon and Fikrig 2003, Carlyon and Fikrig 2006). The 
vacuole enlarges as the bacteria multiply by binary fission and eventually 
forms inclusion bodies in the cytoplasm. These inclusions or “morulae” can 
be identified on microscopic evaluation of blood smears from infected   13
individuals in the acute febrile stage of disease, within the cytoplasm of 
granulocytes (especially in neutrophils) (Gribble 1969, Gribble 1970, 
Rikihisa 1991) Figure 1. 
 
 
 
 
 
Figure 1. Bloodsmear with neutrophil containing two morulae in the cytoplasm. (Pictures courtesy of 
Dr. Harold Tvedten). 
The morulae in equine neutrophils can vary from 0,5 to 5 µm in diameter, 
(Gribble 1969 and 1970, Lewis 1976, Sells et al. 1976), and may contain 
more than one and up to 20 bacteria. On blood smears morulae may be 
seen in from less than 1% up to 20-30% of the neutrophils (Madigan and 
Pusterla 2000). They stain deep blue to pale blue grey with giemsa and are 
fluorescent with acridine orange stains (Gribble 1969). More than one 
morula is often in a single infected c e l l .  I t  i s  n o t  p o s s i b l e  t o  g r o w  t h e  
bacterium in standard cell free media. Successful cultivation may be 
achieved through the use of the human promyelocytic leukemia cell line 
HL-60, the tick cell lines IDE8 and IDE6 and monocytic and granulocytic 
progenitors from human bone marrow (Munderloh et al. 1996, Klein et al. 
1997b, Munderloh et al. 1999). This is mainly performed in research 
facilities and such techniques are seldom available for use in routine 
diagnostic laboratories. 
The bacterium is sensitive to oxytetracycline. Although not commonly 
used clinically, rifampicin, rifabutin and trovafloxacin have also been 
reported to be effective in vitro whereas other antibiotics, such as those in 
the beta lactamase group, are reported to be ineffective against this 
bacterium (Brouqui and Raoult 1992, Brouqui and Raoult 1993, Klein et 
al. 1997a, Horowitz et al. 2001, Davidson and Bjöersdorff 2001).    14
 
 
Table 1. Bacteria previously in the “Ehrlichia group” according to Rikihisa (2000), with their 
new names, and which species, disease name and cell type infected for each of the pathogens 
Ehrlichia group and 
Pathogen 
Affected 
species 
Disease Target  cell 
1. Ehrlichia canis  Dog 
Human 
Canine ehrlichiosis 
Rare, no disease 
Monocyte 
1. E chaffensis  Human 
 
Dog 
Goat 
Human monocytic 
ehrlichiosis 
Unnamed 
Unnamed 
Monocyte 
1. E ewingi  Human 
Dog 
Human ehrlichiosis 
Canine granulocytic 
ehrlichiosis 
Granulocyte 
2. Anaplasma phagocytophilum 
 (formerly the HGE-agent) 
(formerly Ehrlichia equi) 
 
 
 
 
(formerly Ehrlichia 
 phagocytophila) 
Human 
 
Horse 
 
Dog 
 
Cat 
Ruminant 
Human granulocytic 
ehrlichiosis 
Equine granulocytic 
ehrlichiosis 
Canine granulocytic 
ehrlichiosis 
Feline granulocytic 
anaplasmos 
Tick-borne fever 
Granulocyte 
2. Anaplasma platys 
(formerly Ehrlichia platys) 
Dog Canine  cyclic 
thrombocytopenia 
Thrombocyte 
2. Anaplasma marginale  Cattle Anaplasmosis  Erythrocyte 
3. Neorickettsia sennettsu 
(formerly Ehrlichia sennetsu) 
Human  Sennetsu fever   Mononuclear 
leukocyte 
3. Neorickettsia risticii 
(formerly Ehrlichia risticii) 
Horse  Potomac horse fever   Monocyte   15
The vector and the reservoir   
The tick responsible for transmitting A. phagocytophilum in Europe is 
predominantly Ixodes ricinus, whereas in the US the western black-legged 
tick Ixodes pacificus and also Ixodes scapularis seem to be the primary vectors. 
Tick transmission is believed to be the only epidemiologically important 
means of acquiring infection. However, blood contamination may be a rare 
way for transmission as human infection through blood transfusion has been 
reported (McQuiston et al. 2000).  
The tick has a four stage life cycle: egg, larvae, nymph and adult (male or 
female) (Figure 2.) The larvae and the nymph require one blood meal each 
to develop into the next stage. The adult female needs one large blood meal 
to produce eggs. The larvae and the nymphs normally suck blood for 3-5 
and 5-7 days respectively from mammals and birds of all sizes. The adult 
females suck blood during 7-13 days from medium to large mammals 
including the cat, dog, hare, deer, human, sheep and horse. Birds are 
believed to be more seldom involved as a reservoir. Each stage of 
development lasts approximately one year and the entire life cycle often 
takes 3 years, but may vary from 2-6 years (Balashov 1972). Transovarial 
transmission of the bacteria from an adult tick to eggs is not believed to 
occur. Therefore, immature ticks (larvae and nymphs) must feed on infected 
animals to acquire and transmit infection to the successive life stages 
(nymphs and adults respectively). This phenomenon is known as trans-
stadial transmission (Telford et al. 1996, Hodzic et al. 1998). However, 
trans-stadial maintenance of A. phagocytophilum appears to be ineffective and 
may need a large load of bacteria to persist through the moult (Ogden et al. 
2002).   
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Figure 2. The stages (except the egg stage) of the life cycle of Ixodes ricinus in their relative size. The 
nymph is approximately 1.5  mm long. The larvae have three pairs of legs, whereas later stages have 
four leg pairs. (Picture courtesy of Jan Chirico and Gunilla Olsson). 
 
Figure 3. Ixodes tick on the leg belonging to the main supervisor.   17
The adult female is known to infect recipients. Whether the earlier 
stages and the adult male are able to infect recipients is not known at 
present time (J. Chirico, SVA, Uppsala, Sweden personal communication). 
The maintenance of anaplasmal infection in nature is dependent on the 
existence of animal hosts that can harbour anaplasmal organisms for 
sufficient periods of time. The host of the infectious agent must also act as a 
feeding host for the vector. Wild rodents have been suggested as reservoirs 
for A. phagocytophilum (Ogden et al. 1998a, Liz et al. 2000) and also sheep 
and deer (Stuen et al. 1998b, Alberdi et al. 2000, Ogden et al. 2002). Birds 
are believed to act as carriers of infected ticks, rather than serving as 
reservoir themselves (Bjöersdorff et al. 2001). 
Serologic evidence of host reservoir capacity has further been reported in 
rodents including rats, mice and voles, elk and roe-deer, foxes, raccoons, 
opossums, chipmunks and coyotes (MacLeod and Gordon 1933, Telford et 
al. 1996, Walls et al. 1997, Lockhart et al. 1997, Ogden et al. 1998a, Foley 
et al. 1998, Alberdi et al. 2000, Liz et al. 2000). 
  Clinical signs – different species 
Among  sheep, goats and cattle in Europe tick-borne fever is mainly 
reported as a febrile disease. Clinical signs may vary from mild detectable 
illness to severe febrile disease, sometimes accompanied by sequelae such as 
secondary or opportunistic infections, hemorrhage, abortions and sterility 
(Foggie 1951, Ervin 1981, Dumler et al. 2001). In ruminants the disease is 
also called pasture fever. In lambs there is often fever and acute disease, even 
sudden death can eventually occur (Stuen et al. 2003). However, the 
infection in lambs is also associated with predisposition for other infections 
(Foggie 1956, Foggie 1957) such as bacterial pneumonia (i.e. 
staphylococcosis and pasteurellosis), and with reduced weight gain (Stuen et 
al 2002b). Classical signs in lactating cows include high fever, often more 
than 41ºC and more than 50% reduction in milk production (Cranwell and 
Gibbons 1986, Larsson et al. 2006).  
In humans the infection manifests as an acute nonspecific febrile illness 
characterized by high fever (temperature >39ºC), rigor, generalized 
myalgia, severe headache and malaise (Bakken et al. 1994, Aguero-
Rosenfeld et al. 1996, Bakken et al. 1996, Wallace et al. 1998, Bakken and 
Dumler 2000), and has sometimes been called “summer influenza”. The 
illness in humans often lasts only for a few days. Rarely, however, patients 
have been ill for several weeks in the absence of appropriate antibiotic 
therapy (Backen and Dumler 2000) especially in the 90’s when the disease   18
was “new” in humans and awareness of this infection in humans was not 
wide-spread. Fatalities are rare but may occur in less than 1% of cases, 
especially in elderly and immuno-compromised persons (Bakken and 
Dumler 2000, Olano and Walker 2002).  
In the horse EGA is described as an acute disease with an incubation 
period of less than 14 days, characterized by high fever, depression, 
inappetence, staggering or ataxia, distal limb edema and hematologic 
alterations, such as thrombocytopenia, neutropenia, lymphopenia and mild 
anaemia (Gribble 1969, Madigan 1993). Petechiation of mucous membranes 
and icterus may also occur. Clinical signs usually disappear without 
treatment within 7-14 days in horses but a more rapid recovery will occur 
with oxytetracycline treatment (Madigan and Pusterla 2000).  
In the dog the typical clinical signs of granulocytic ehrlichiosis include 
anorexia, depression, fever, and reluctance to move (Greig et al. 1996, 
Egenvall et al. 1997).   
  Subclinical infection  
Infection without development of clinical signs of disease appears to exist in 
sheep (Foggie 1951, Stuen and Bergström 2001b), cattle (Hudson 1950, 
Larsson et al. 2006), horses (Madigan et al. 1990, Madigan and Pusterla 
2000), dogs (Egenvall et al. 2000a, Egenvall et al. 2000b) and humans 
(Dumler et al. 2005, Dumler et al. 1997). The proportion of infected cases 
that actually develop clinical disease is not known. 
  Diagnosis 
Diagnostic criteria for EGA include presence of typical clinical signs of 
acute disease, demonstration of inclusion bodies in neutrophils and presence 
of antibodies in serum (most often using IFA-test but also ELISA-tests are 
available) and a positive PCR signal for DNA from Anaplasma 
phagocytophilum; the latter being the most sensitive diagnostic tool (Pusterla 
and Madigan  2007). Differential diagnoses to EGA include viral arteritis, 
purpura heemorrhagica, encephalitis, liver disease (Madigan and Pusterla 
2000) or any systemic infection with fever and no localized signs. 
  Treatment, immunity and prevention 
Effective treatment for EGA is accomplished using oxytetracycline 6-7 
mg/kg i.v. once daily for 5-7 days (Madigan 1993, Madigan and Pusterla   19
2000). Fever will usually disappear within 12-24 hours and other 
accompanying signs abate within a few days. A prompt recovery after 
oxytetracycline injection is considered to support the diagnosis. Mortality is 
very low but fatalities may occur from trauma due to incoordination of the 
limbs in the acute stage or due to secondary infection (Gribble 1969, 
Madigan and Pusterla 2000). In rare cases fever with anaplasma bacteremia 
has recurred some weeks after first infection (Madigan 1993). Possible 
explanations, although not well evaluated, may include exacerbation of 
persisting bacterial infection following a too short course of antibiotic 
treatment (Madigan 1993) or possibly reinfection through new tick-bites 
before immunity has fully developed.  
The time of immunity after clinical disease is not completely known. In 
inoculation studies horses have been refractory to develop disease again 
when challenged 2, 5, 6, 12 and in one case after a 20-month period 
(Gribble 1969) after initial clinical disease. This is consistent with another 
report where ponies that had recovered from clinical disease after 
experimental infection, failed to develop detectable reinfection upon 
challenge (Nyindo et al. 1978). Antibodies have been described to persist at 
least for 5-12 months after natural infection (Van Andel et al. 1998, 
Artursson et al. 1999) and at least 300 days after experimental infection 
(Nyindo et al. 1978). 
The time for transmission of the infective agent has been studied in 
experimental infections and transmission is thought to occur within a 
window of 40-48 hours of feeding. It has thus been suggested that through 
removal of ticks prior to 36 hours of feeding only few clinically apparent 
anaplasma infections would occur (Hodzic et al. 1998, Katavolos et al. 
1998). Further, according to Lotric-Furlan et al. (2001) the time from initial 
tick infestation to transmission of the HGE-agent is at least 24 hours. 
Continuous removal of ticks and use of insect repellents appears to be of 
some use to prevent infection. These aspects are similar to the situation of 
the tick-borne infection with Borrelia species where transmission of the 
infective agent is known not to, or only rarely to occur within the first 24 
hours (Piesman et al. 1987, Kahl et al. 1998, Ramamurthy et al. 2002, 
Hojgaard et al. 2008) as opposed to the chain of infection for the tick-borne 
virus of tick borne encephalitis in humans where the agent may be 
transferred earlier after tick bite. There is presently no vaccine available 
against A. phagocytophilum (Pusterla and Madigan 2007).    20
  Seroprevalence studies 
A number of seroprevalence studies of antibodies to A. phagocytophilum in 
horses have been reported from different parts of the world with 
seroprevalence varying from 0% to 17% in investigated horses (Table 2) 
(Madigan et al. 1990, Bullock et al. 2000, Egenvall et al. 2001, Teglas et al. 
2005, Leblond et al. 2005, Levi et al. 2006, Amusategui et al. 2006). 
Inclusion criteria and clinical information on the material have varied. It has 
been recorded in endemic areas that at one farm 50% of healthy horses can 
be seropositive (Madigan et al. 1990).  
In selected serosurveys of humans similar seroprevalences have been 
noted. Of 361 healthy German recruit soldiers 14.9% were seropositive and 
another 5.3% seroconverted during military service without developing 
signs of HGE (Woessner et al. 2001). In another study, of 159 adult blood-
donors in New York state, 11.3% were seropositive to HGE and 
seropositivity was further noted in 21% of 42 patients with borrelia-caused 
erythema migrans (Aguero-Rosenfeld et al. 2002). In Sweden, 185 of the 
356 permanent residents on the Koster islands coast were screened for 
HGE-antibodies and 11.4% tested seropositive (Dumler et al. 1997). 
Granulocytic anaplasmosis is considered to be an emerging disease in 
humans as well as in dogs and horses in the western hemisphere (Rikihisa 
2000, Leblond et al. 2005, Blanco and Oteo 2006, Beltrame et al. 2006, 
Santos et al. 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   21
 
Table 2. Selected reports of serosurveys of antibodies to Anaplasma phagocytophilum  in horses            
Study Year  of 
publication  
Nr of 
horses 
included 
% sero-
positive 
* 
Geographic 
area 
Population 
Madigan et 
al.  
1990 240 10.4  California 
US -
foothills 
“Routine health care” 
cases and competing 
endurance horses 
Madigan et 
al.  
1990 95  3.1 California 
US -non-
foothills  
“Routine health care” 
cases and hospital 
patients with non-
medical problems 
Bullock et al.  2000  741  10.8  Minnesota, 
Wisconsin 
US 
Serobank -horses (543) 
originally tested for 
infectious anaemia- plus  
healthy horses sampled 
for this study (198) 
Egenvall et 
al. # 
2001  2018  16.6  Sweden  400 healthy horses and 
1616 randomly picked 
patients visiting equine 
clinics with detailed 
clinical status 
Teglas et al.  2005  74  13  Guatemala  Owners brought horses 
from 7 villages for 
“preventive veterinary 
care and minor medical 
treatment” 
Leblond et al.  2005  424  11.3  France -
southern 
 
Levi et al.  2006  300  0  Israel  Population “from farms 
throughout Israel” 
Amusategui 
et al. 
2006 46  6.5 Spain  - 
north-
western 
Not defined 
* IFA was used for antibody detection in all surveys except for Leblond´ et al. where             
ELISA was used. 
# =included in this thesis 
  Experimental infection in horses and different strains 
The clinical and hematological findings on EGA were described in detail by 
Gribble in his pioneering work (Gribble 1969, Gribble 1970). He infected a 
large number of horses, followed them clinically and euthanized them at   22
different stages into clinical disease, describing the pathological changes in 
detail. The agent used in those studies was the strain found in naturally 
infected horses in California and it was by then named Ehrlichia equi. Later, 
Nyindo et al. (1978) performed experimental infections with the same 
agent, with the purpose of studying the immune response. Both humoral 
and cell mediated immunologic responses were demonstrated (Nyindo et al. 
1978). 
Development of new techniques has made it possible to analyze the 
DNA sequence of specific genes. The 16S rRNA gene has become a 
standard method to assess the phylogenetic relationship between bacterial 
genera and species, since it is a stable and well conserved gene. It was 
reported that the isolate of A. phagocytophilum (by then named Ehrlichia 
species) found in infected horses and dogs in Sweden (Johansson et al. 1995) 
differed in 3 positions in 16S rRNA gene from the deposited Californian E. 
equi agent and in two positions from the Ehrlichia phagocytophila depositied in 
Genbank by Anderson et al. (1991). However it was identical to the agent 
found in clinically diseased humans – the so-called “HGE-agent” deposited 
in Genbank (Chen et al. 1994) with respect to the 16S rRNA gene.   
Later, more isolates from Swedish horses showed the same 16S rRNA 
sequence (Björsdorff et al. 2002) as did a horse isolate from Switzerland 
(Pusterla et al. 1998a) as well as isolates from the middle and eastern USA 
(Madigan et al. 1996, Bullock et al. 2000). After it was found that the 
HGE-agent was infective to horses and gave rise to disease in horses 
clinically indistinguishable from EGA (Madigan et al. 1995), the horse has 
been used as an animal model for the disease in humans. Several 
experimental HGE-agent infections in horses are reported (Table 3).  
Isolates pathogenic for cattle (formerly named Ehrlichia phagocytophila) 
have failed to induce clinical disease when inoculated in horses (Pusterla et 
al. 1998b)  and conversely, isolates from horses have failed to induce clinical 
disease in lambs and cattle (Stuen et al. 1998a, Pusterla et al. 2001) despite 
seroconversion in both instances. These findings suggest that, although E. 
phagocytophila, E. equi, the Swedish isolate from horses previously named 
Ehrlichia species and the HGE-agent are all currently included as a single 
species  A. phagocytophilum, there appears to be differences in biologic 
capacity to induce clinical infection in different animal species.  
Several 16S rRNA gene variants of A. phagocytophilum with minor 
nucleotid differences has been reported in isolates from sheep (Stuen et al. 
2002a, Stuen et al 2003). Further, A. phagocytophilum isolates from different 
geographic locations have been sequenced also concerning other genes and 
it appers to exist geographic differences in the Ep-ank and groESL heat   23
shock operon genes (Chae et al. 2000, Massung et al. 2000). Further, global 
diversity in the MSP2 (44) outer membrane protein have been reported 
(Barbet et al. 2006).  
 
Table 3. Experimental infections in horses with strains currently included in the species  A.phagocytophilum 
*=no of horses inoculated in study, ¤=no of infected neutrophils, & = E. phagocytophila, 
#=included in this thesis 
Author, year  Agent  Donor  No. 
* 
Reason for study  Infective 
dose ¤ 
Gribble 1969  E. equi  horse  43  describe the disease   
Nyindo 1978  E. equi  horse    study immune response   
Barlough  et al. 
1995 
 E equi   (after 
HGE) 
horse  1  does HGE give immunity to E. 
Equi 
 
Madigan et al. 
1995 
HGE  human  1  test if HGE is infective to horses   
Barlough et al. 
1996 
E. equi  horse  1  to test a PCR  4.5x10 
7 
Franzén et al. 
1998 
E. species   
(Swed. isolate) 
horse  1  can persistence occur?  2 x 10
7 
Pusterla et al. 
1998b 
E. phag. &  cow 4 does  E. phag. give rise to EGE in 
horses 
4.6x10
7 
Chang et al. 
1998 
HE  human  2  produce material for an IFA-test   
Reubel et al. 
1998 
 
Not specified   ticks  3  can I. pacificus exp. infect horses?   
Pusterla et al. 
1999a 
HE  horse  3  compare tick infection route with  
i.v. inf. route  regarding  
6.5x10
6 
     “  HE  human  1  bacterial  burdon  in  infected     
     “  HE  ticks  4  recipients   
Pusterla et al. 
1999b 
E. phag. & Swiss 
isolate 
cow 2 does  E.phag. infection in a horse 
give rise to  immunity to 
4.5x10
7 
      “  "HGE-like" 
Swiss isolate 
horse 2  HGE-like  infection  4.5x10
7 
Pusterla et al. 
2000 
HE cell 
culture 
4  is HGE from cell culture infective 
in horses and in different passages 
1x10
6 
Pusterla et al. 
2001 
HGE and E. equi 
resp. 
cell 
culture 
2  positive control for inf. in cattle   1x10
6 or 
15x10
6 
Franzén et al. # 
2005 
A.phag. 
Swed.isolate 
horse  6  describe signs of EGA with a 
Swedish isolate and may 
persistence occur? 
2x 10 
7  
or 6 x10
6    24
  
                                                                                                                                   
Persistence of infection  
Extended persistence of infection by A. phagocytophilum has been described 
in sheep and cattle (Foggie 1951, Ogden et al. 1998b, Stuen et al. 1998b, 
Stuen et al. 2001a, Stuen och Bergström 2001b), dogs (Egenvall et al. 
2000a, Egenvall et al. 2000b, Alleman et al. 2006) and calves (Larsson et al. 
2006). 
In dogs and calves persistence of infection appears to be clinically silent 
in the convalescent phase (Egenvall et al. 2000a, Larsson et al. 2006) 
whereas persistence of infection in lambs has been associated with 
predisposition to secondary infections such as pneumonia (Foggie 1951, 
Foggie 1956, Stuen 2007) and reduced weight gain (Stuen et al. 2002b).  
In neither the horse nor humans has long term or persistence of the 
infection been described in the literature, either in case reports of more 
extensive studies or experimental infections (Nyindo 1978, Backen and 
Dumler 2000, Madigan and Pusterla 2000, Lotric-Furlan et al. 2001, 
Pusterla and Madigan 2007). There is however a single report on PCR-
positive tissues 37 days after experimental infection with the HGE-agent in 
the horse (Chang et al. 1998) (with no clinical signs of disease after acute 
fever for 3-4 days). Moreover, in one own early equine challenge study 
PCR-positivity was demonstrated (without clinical signs after acute fever) 
56 days after inoculation of a horse-derived isolate (Franzén et al. 1998). 
However, among veterinarians in the field in Sweden and other 
European countries there are clinical suspicions that infection with A. 
phagocytophilum in the horse may also induce a milder but more chronic 
form of disease with other than the well described signs of acute disease. 
This is based predominately on associating seropositivity against A. 
phagocytophilum in horses with poorly defined clinical abnormalities such as 
fatigue, unwillingness to be ridden, poorly localised lameness or 
polyarthritis, behavioural problems, stiffness and musculoskeletal soreness 
(Bjöersdorff and Myrin-Carlsson 1998) and in selected cases, apparent 
improvement in clinical signs following treatment with tetracyclines.   
Currently in Sweden it appers that a large number of horses are treated 
with oxytetracyclines because of suspected “chronic granulocytic 
anaplasmosis” despite the lack of substantial, scientific data available to 
support this. With this as a clinical background, and lack of data on longer   25
term effect of A. phagocytophilum infection in the horse, the studies in this 
thesis were performed.      26
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  Aims of the studies  
Aims of the studies were to 
through serosurvey: 
•  determine the seroprevalence of antibodies to Anaplasma 
phagocytophilum in a fairly large and defined population of horses in 
Sweden, 
•  evaluate in a large material of Swedish horses whether seropositivity 
to Anaplasma phagocytophilum was statistically associated with any 
sign of disease or any specific diagnosis (excluding acute 
granulocytic anaplasmosis), 
 
through experimental infection: 
•  describe clinical signs and laboratory changes and their temporal 
changes in infection with a well defined Swedish isolate of A. 
phagocytophilum, 
•  study whether the infective agent may persist in horses after acute 
clinical disease had disappeared, 
•  evaluate whether clinical or pathological signs of eventual persistent 
infection with A. phagocytophilum was detectable after acute disease 
signs had abated.   28
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  Comments on materials and methods 
  The seroepidemiologic study (Paper I) 
  Sampling 
A cross-sectional study was done using 17 equine clinics all affiliated to 
ATG (the Swedish Horse Race Totalizator board). The clinics were 
localized all over the country, from Malmö in the south to Boden in the 
north of Sweden. All kinds of horses (not only race horses) visit these clinics 
for a large variety of reasons. Some of the horses were not presented for 
disease problems but rather for prophylactic purposes or routine procedures 
(i.e. vaccination, teeth floating or pre-purchase examination).  
Each clinic was randomly assigned (by lottery) 2 days each month during 
12 months for sampling. There were from 2 to 19 samples per clinic per 
month. The number of requested samples from each clinic was proportional 
to the case-load for each clinic. During sampling days, the owners/trainers 
were informed and asked to participate in the study. Every horse visiting 
the clinic during sampling day was sampled (unless the owner did not want 
to participate) until the requested number of horses was reached.  
  Questionnaires  
Participating owners/trainers were asked to complete a questionnaire 
regarding demographic parameters, tick exposure and health status of the 
horse (including if the horse was considered to have been healthy the 
previous year).  Parameters asked for included; gender, age, breed, usage, 
geographic location, season, pasture access, outdoor confinement and tick 
exposure of the horse. Additionally, the veterinarians were asked to 
complete questions concerning the health status of the horse including   30
reason for visit and the final diagnosis. Recorded reasons for visit were pre-
purchase examination, castration, vaccination, lameness examination, disease 
(specified by signs/diagnosis) or other. Recorded signs according to the 
owner (anamnestic details) or the veterinarian (clinical findings) included 
abortion, wasting, fever, diarrhoea, integumentary problems, unwillingness 
to be ridden, tendon injuries, stiffness, respiratory problems, fatigue, 
staggering, traumatic injuries and ophthalmologic disease, as well as  referral 
for radiographic examination.  
  Serologic test to Anaplasma phagocytophilum 
Two-fold dilutions of fresh sera were added to slides precoated with E. equi 
antigen. Bound antibodies were visualised by fluorescein-isothiocyanate 
(FITC)-conjugated rabbit-anti-horse immunoglobulin (Ehrlichia equi antigen 
Protate, St Paul, MN, USA) when slides were examined by fluorescence 
microscopy. In this test, an IFA titer > 1:40 was considered positive. The 
test was accredited according to the EN ISO /IEC 17025 (International 
Organisation of Standardization) with inclusion of positive and negative 
controls. The limit for seropositivity was originally set by calibrating the test 
according to results obtained from external laboratories and the test is 
continuously checked in ring controls with other laboratories to ensure 
same levels of results. The IFA-test is the most used test according to the 
literature for serologic testing of A. phagocytophilum.  
  Healthy group of horses 
The owner/trainer was asked whether the horse was considered totally fit 
for the task requested at the time of sampling, and also if this had been the 
case for the previous 12 months. The questions were designed to construct 
a “healthy group” of horses in the study. A horse was placed in the healthy 
group of horses if it was considered fit at the time of sampling as well as 
during the previous year and visited the clinic for procedures not associated 
with any prevalent disease (i.e. pre purchase examination, vaccination etc) 
with one exception. Horses were included in the healthy group also if they 
were considered healthy during the past 12 months and visited the clinic 
due to acute traumatic injuries such as wound injuries, splint bone fractures, 
sore sole as it was considered that acute traumatic events were unlikely to 
be associated with Anaplasma infection. 
  Statistical analysis 
Geometric mean titers (GMT) were determined for all seropositive horses, 
for seropositive horses in the healthy group and for the remaining   31
seropositive horses i.e. the seropositive horses that were not considered 
healthy. For clinical signs, disease variables and for whether the horses were 
in the healthy group or not, the chi-square test was used to investigate 
associations and Fischer´s exact test was used when expected values were 
too low for the chi-square test to be valid. To compare titers in healthy and 
“non-healthy” horses the continuity corrected Wilcoxon two-sample test 
was used.  
Logistic regression was used to model seropositivity. Included factors in 
the unreduced models were: age, gender, breed, racing, region and season. 
A disease model (n=1983) was developed to evaluate associations between 
disease factors with respect to positive Anaplasma serotiter and a tick 
exposure model (n=1754) for tick exposure factors. Factors associated with 
disease status were included in the disease model if at least 50 horses were 
affected. Disease variables were also tested in the multivariable models if 
they were significantly associated (two-sided tests P<0.05) with the 
outcomes in the unconditional analyses. In the tick exposure model two 
variables associated with exposure to ticks were included: pasture access and 
outdoor confinement. The question about tick exposure according to 
trainer/owner responses was not included since many were unaware of 
exposure level. Model building was by backward elimination. Full main-
effect models were reduced until the P ≤ 0.05 (change in deviance between 
one model and another model with one less variable), after which all 
possible two-way interactions were tested. Confidence limits (95%) were 
constructed around prevalence odds ratios using the profile likelihood. P ≤ 
0.05 (two-tailed) was considered significant. The Hosmer-Lemeshow test 
was used to evaluate goodness-of-fit. SAS (SAS Institute, Inc., Cary, NC) 
was used to perform all analyses with PROC GENMOD used for the 
multivariable modeling and PROC LOGISTIC for the Hosmer-Lemeshow 
goodness-of-fit-test. 
  Experimental infection (Papers II, III and IV) 
  Animals 
Five Standardbred horses, aged 5–10 years, and one 19-year-old 
Warmblood riding horse were used in this study. The Standardbreds had 
recently retired from racing careers. All horses were clinically healthy based 
on a detailed clinical examination and routine blood chemistry and CBC. 
Horses were negative for antibodies to A. phagocytophilum as well as Borrelia 
burgdorferi (National Veterinary Institute, Uppsala, Sweden). The horses   32
were housed in individual stalls in a shared room, without direct contact 
with other horses, in the research animal area of the Department of Clinical 
Sciences, Faculty of Veterinary Medicine and Animal Science, Swedish 
University of Agricultural Sciences, Uppsala, Sweden. Hospital staff 
attended the horses, which were allowed daily access to outdoor, 
vegetation-free, sand paddocks. The study was carried out in winter-spring 
seasons.  
  Experimental infection and inoculate 
All infective blood used for the experiment originated from a clinical case of 
EGE in a Swedish horse. Blood for infection was collected from 2 
experimentally infected horses during the acute phase of infection; donor 1 
was infected with blood from the clinical case, as described by Franzén and 
others 1998, and donor 2 was the 1st horse infected in this current group of 
experimental horses. Horses 1 and 2 were infected with the blood from 
donor 1 and the other 4 horses were infected with blood from donor 2. 
Donor blood for the present study was harvested in sodium citrate-
containing blood bags during the acute phase of illness, and held at -70°C. 
The infective blood was thawed in cold running water and then infused 
into the recipient horses through the jugular vein (day 0). The dose was 
calculated to be 2 x 10
7 infected neutrophils (horses 1 and 2) or 6 x 10
6 
infected neutrophils (horses 3–6). DNA sequencing for three genes was 
performed on the inoculum and from samples from all horses-16S rRNA 
(1428 bp), GenBank accession number AY527213, the groESL (1339 bp) 
GenBank accession number AY529489 and the ankA (1735 bp) GenBank 
accession number AY529487 - and confirmed that the organisms were 
identical in all instances. The 16S rRNA gene sequence proved to be 
identical to the A. phagocytophilum sequenced from Swedish horses as 
described by Johansson et al. (1995) and Engvall et al. (1996) and to the 
HGE agent. 
  Clinical evaluation and sampling of horses during the acute stage (Paper 
II) 
All horses were examined clinically on a daily basis. The evaluation 
included assessment of general demeanour and behaviour, body 
temperature, appetite, and passage and consistency of faeces. Additionally 
the examination consisted of assessment of oral mucous membranes, 
auscultation of the cardio-respiratory system, recording of heart and 
respiratory rates, assessment of body posture and movements in box and 
during transfer to the paddock and in the paddock for any gait abnormality   33
or detectable lameness, and assessment of musculature, extremities, body 
and head for changes such as soreness, stiffness, lameness or edema.  
Blood samples for microscopic examination for inclusions and for PCR 
evaluation were obtained on a daily basis, whereas samples for CBC and 
serology were obtained during the period when horses showed signs of 
disease, for the most part daily or on alternate days. Blood was drawn from 
the jugular vein via catheter or needle puncture to tubes containing 
ethylenediaminetetraacetic acid (EDTA) for CBC and into plain glass tubes 
for serology. 
  Clinical evaluation, sampling and experimental design during the follow-
up period (Paper IV) 
Following spontaneous recovery from acute experimental EGA (i.e. after 
day 21) p.i. horses were monitored until 98-129 p.i., after which they were 
euthanized and subjected to post mortem examination. During this period a 
complete clinical examination was performed every day in the same manner 
as during the acute phase. In addition the presence of lameness or ataxia was 
evaluated daily while the horses moved freely in the stall and/or in a 
paddock. A separate clinical lameness examination with trotting on a hard 
surface and flexion test of all four limbs was performed before the trial 
started and was repeated, on 2-3 occasions depending on the follow-up 
time. A final lameness examination was performed immediately prior to 
euthanasia and post-mortem examination.  
Blood samples for analyses for PCR signal and inclusion bodies were 
collected on a daily or alternate day basis. Blood sampling for routine 
hematologic analysis, and serology against the EGA agent were obtained on 
a weekly basis.  
After 60 days p.i. the horses were also subjected to periods of various 
“stress interventions” that could potentially hamper immune function. One 
horse (5) was trained on a treadmill at a walk and moderate trot for 15-25 
minutes on three separate occasions. Horses 3 and 4 were placed in a trailer 
and transported on a major highway for four hours. Further, following day 
72 p.i. all horses were administered dexamethazone (0.1 mg/kg) (Vorenvet 
Boeringer Ingelheim, Vetmedica, Copenhagen, Denmark) i.m. for three 
days on one occasion for horses 1 and 5 and on two occasions for horses 2, 
3 and 4. 
  Serology, PCR and hematology 
The serologic IFA-test for A. phagocytophilum is described and discussed 
earlier in comments on the seroepidemiologic article (Paper I).    34
DNA from EDTA blood samples was extracted by the QIAamp Blood 
Extraction Kit from QiaGen (Hilden, Germany). The PCR primers used 
were as described by Goodman et al. (1996a) in the Errata of this article 
(Goodman et al. 1996b).  
A number of PCR primers for A. phagocytophilum detection have been 
published, of which several were evaluated by Massung and Slater (2003). 
They reported problems with the Goodman PCR and therefore specificity 
and sensitivity for this test was not presented in their paper. As the 
Goodman PCR performed well in our laboratory, we speculate that the 
primers tested by Massung and Slater might be the ones from the original 
Goodman paper, in which there was a misprint in the sequence, and not 
the amended primer sequences from the Goodman Errata (Goodman et al. 
1996b). 
Before the blood samples were analyzed from the experimental study, 
the PCR methods published at the time were compared. The Goodman 
method was found to be the most specific and sensitive method in our 
hands (data not shown).  After the Massung and Slater paper was published 
we evaluated the method that was used (Goodman) by comparing it to two 
of the PCR methods they reported as being the most sensitive, i.e. with the 
primers ehr521-ehr790 as described by Kolbert (1996) and the primers 
msp2-3f-msp2-3r as described by Massung (Massung, presented at the 
EUWOG-ASR Joint Meeting, Marseille, France, 1999 Program and 
Abstracts, p. 6), (PCR methods not readily found when searching 
PubMed). We found the ehr521-ehr790 PCR less sensitive and the msp2-
3f-msp2-3r more sensitive than the Goodman PCR (data not shown), the 
latter being about five to ten times more sensitive than the method used in 
this study. However, taking into account the amount of blood tested in the 
present study compared to Massung and Slater (1 mL and 0.2 mL 
respectively) the detection limit is approximately the same, corresponding 
to approximately 50 bacteria in one ml of blood (data not shown).  
Total hemoglobin, red blood cell count, total and differential white 
blood cell and thrombocyte counts were analyzed electronically
 (Cell-Dyn 
350, Abbot Laboratories, Abbot Park IL, USA). Microscopic evaluation of 
blood smears was used to detect inclusion bodies in the neutrophilic 
granulocytes indicative of Anaplasma  bacteria within those cells. Blood 
smears were stained with Giemsa for light microscopy and with Acridin 
orange for fluorescent microscopy. At least 200 neutrophils in every blood 
sample were examined for presence of inclusions.   35
  Post mortem examination  
The horses in paper IV were euthanized by intravenous injection of an 
overdose (10 grams) of sodium thiopental (Pentothal® Natrium, Abbott 
Scandinavia AB, Solna Sweden). A full necropsy was carried out on all five 
horses within a few hours after euthanasia at the Department of Pathology, 
National Veterinary Institute, Uppsala, Sweden. Tissue samples from 
internal organs (Table 4) were fixed in 10% buffered formalin, processed 
routinely, embedded in paraffin, sectioned and stained with hematoxylin-
eosin (HE)-stain. Tissue samples from lymph nodes, lung, liver, spleen and 
kidney were submitted for bacteriological examination. The horse in Paper 
III was examined within 10 hours of death. For bacteriological examination 
the same samples were collected as for the other horses with addition of 
synovial membrane and brain. Samples for histological examination were 
collected from kidneys, heart, lung, spleen, liver, muscle and muscle fascia, 
spinal cord, and brain (cortex, basal ganglia, hippocampus and 
mesencephalon) from this horse. 
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Table 4.  
Tissue specimens from post mortem in five experimentally infected horses 
* = histopathologic examination  
# = PCR analysis  
           &= three different specimens from the same organ analyzed with PCR   
           x = two different specimens from the same organ analyzed with PCR 
 
   Horse number 
Organ/tissue 
specimen 
1 2 3  4 5 
Bone Marrow  * #  * #  * #  * ¤&  * # 
Adrenal gland  *  * #  * #  *  * 
Fascia  * #  * #  * #  * #  * # 
Brain  * #&  * #  * #  * #  * # 
Meninges  *  * #  * #  * #  * # 
Choroid  plexus #       
Cerebrospinal fluid    #  #    # 
Spinal cord  * #  * #  * #  * #  * # 
Myocard  * #  * #  * #  * #  * # 
Joint capsule  * #  * #  * #  * #  * 
Synovia    # #  # # 
Liver  * #  * #  * #  * #  * # 
Lung  * #  * #  * #  * #  * # 
Lymph node  * #  * #  * #  * #&  * # 
Spleen  * #x  * #  * #  * #&  * # 
Skeletal muscle  * #  * #  * #  * #  * # 
Kidney  * #  * #  * #  * #  * # 
Peritoneum  *  * #  * #  *  * 
Intestine  * #  * #  * #  * #  * # 
Unrinary bladder  * #  * #  * #  * #  * # 
  Immunohistochemistry and DNA extraction for PCR on tissue samples 
Immunohistochemistry for the detection of A. phagocytophilum was applied 
to tissue sections of the liver and kidneys of the horse in paper III, using a 
high-titre serum (1:10,000) from another experimentally infected horse as   37
the primary reagent; liver and kidney sections from an uninfected horse 
served as negative controls.  
Samples from internal organs (Table 4) from all horses in Paper IV were 
frozen in liquid nitrogen and stored at –70˚C until processing. DNA from 
approximately 25 mg of each organ sample was extracted, and PCR analysis 
for A. phagocytophilum was performed as described earlier.   38
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Comments on results and discussion 
   
  Serosurvey (Paper I) 
The population sampled was a cross-section of horses attended at the 
country’s network of racing commission (ATG) equine clinics in 1997-
1998 but does not represent the total Swedish horse population. Since the 
population is derived from horses visiting equine clinics, it is assumed there 
is overrepresentation of active, training and competition horses i.e. 
racehorses, dressage horses, show jumpers and riding horses and 
underrepresentation of foals and yearlings, broodmares, breeding stallions, 
draft horses and horses under more extensive management and usage 
conditions.     
The cross-sectional study showed that 336 out of 2018 horses examined 
were seropositive to A. phagocytophilum corresponding to 16.6% of the 
horses. The geometric mean titer (GMT) was 1:86 and the range was 1:40-
1:1280. Statistical differences in the seroprevalence were found for different 
regions of Sweden with the lowest prevalence in the northern part. This 
was not surprising as it is well known that ticks are more seldom found in 
the north of Sweden (Figure 4). In the group of healthy horses the 
seroprevalence was 15.5% and in the rest of the horses – from here-on 
called “the clinical signs group” 16.9%. The GMT for A. phagocytophilum in 
the healthy group was 1:94 as compared to 1:84 in the “clinical signs 
group”. Comparing healthy horses with “clinical signs horses” there was no 
statistical difference in the seroprevalence to A. phagocytophilum (Table 5).  
Data on demographic variables were relatively similar between the both 
groups although age was slightly lower in the healthy group.    40
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The seroprevalence of antibodies                                                      
to to A. phagocytophilum by clinic.                                                                      
The map shows the location of the clinics. 
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In the multivariable disease model, when controlling for demographic 
factors, no disease variables remained statistically significant with respect to 
seropositivity for Anaplasma. The factors with remaining association in both 
the multivariable models (disease model and tick exposure model) included 
age (higher when older), positive titer to Borrelia and season (lower odds 
ratios (OR) in April to September, compared to January-March). This 
finding is difficult to explain given that tick exposition is likely to be high 
during the summer.  
The middle and south region had higher ORs compared to the north 
region. However there was an interaction with racing, so that racing horses 
in both the south and middle region had relatively low ORs (data not 
shown). The ORs also increased with increasing access to pasture the 
previous year.  
Further in the tick exposure model pasture access was associated with 
seropositivity. Both these latter findings may be explained by that without 
access to pasture (which race horses seldom have as they commonly are 
located on trace tracks and racing camps) exposition to ticks and risk for 
infection is relatively low.  
From a clinical point of view it was concluded that there was no 
association between for instance lameness, arthritis, fatigue, unwillingnesss 
to be ridden (which have been suggested to be linked to seropositive 
horses) or any other of tested clinical signs and a positive titer to A. 
phagocytophilum.  
Together with the findings of high overall seropositivity in many 
geographical areas and the fact of no difference in seroprevalence in healthy 
and clinical signs group, this study gives no support to the suggested 
association between positive serotiter and any sign of disease that have been 
suggested associated to positive serotiters with suspicion of chronic 
persistent infection with A. phagocytophilum. 
Table 5.  Results of the IFA-test comparing the healthy and clinical signs groups  
 
  Healthy group  Clinical signs group 
No. of horses  400  1618 
% seropositives  15.5 ¤  16.9 ¤ 
geometric mean titer  1:94 *  1:84 * 
range 1:40-1:640  1:40-1:1280 
¤ non-significant difference Chi square test  (P=0.49) 
* non-significant difference Wilcoxon two-sample test (P=0.55) 
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  Experimental infection 
  Acute stage (Paper II) 
In this study it was possible to induce acute disease in horses with a Swedish 
isolate of A. phagocytophilum. All horses developed typical signs of EGA 
including fever, depression, reduced appetite, distal limb edema, leukopenia 
and thrombocytopenia. However, one horse died suddenly and 
unexpectedly two days into clinical disease. This horse is discussed 
separately (Paper III). The clinical course in the 5 remaining horses was 
almost identical to what is described from the United States (Gribble 1969, 
Madigan 1993). However, icterus, as reported in earlier work, was not 
noted in these horses. 
The PCR test turned positive several days before the first clinical signs 
appeared. The temporal events of fever, PCR positivity, neutrophil 
inclusions and serocoversion were similar in the different horses figure 
(Figure 5). One small, but clinically important difference between the 
present study and Gribbles work, (Gribble 1969, Gribble 1970) was that 
inclusion bodies were first noted several days into clinical disease. This was 
contrary to the report by Gribble where inclusion bodies were noted 
simultaneously with onset of fever. The discrepancy may be explained by 
variation in laboratory methods. In Gribble’s work very small or single 
inclusions were also recorded as inclusion bodies.  
In the current study inclusions were judged to be present when distinct 
morulae were seen, without strive to identify other possible small 
intracytoplasmatic changes that eventually may be mistakenly deemed as 
“small early inclusions”. For example, false positive interpretations may 
occur due to toxic granulation, Döhle bodies, superimposed platelets or 
contaminant particles (Walker 1999). This minor difference is clinically 
important, because if inclusions are used as the definite diagnostic criterium, 
the diagnosis may be missed during the first couple of days of high fever, 
which often is when the veterinarian is requested to examine the horse.  
It is obvious that PCR has a wider diagnostic window for detection of 
the bacterium in peripheral blood than do inclusion bodies and accordingly 
PCR appears to be the best tool for a definite diagnosis of acute EGA. 
Fever was the first sign and distal limb edema the last to occur. It appears 
that limb edema should not be expected during the first couple of days of 
fever. Further, the clinical signs of disease disappeared without antibiotic 
therapy in less than 14 days in all horses. All horses developed mild and 
transient leukopenia, neutropenia, lymphopenia, thrombocytopenia and 
anaemia seen after day 9 p.i. and for approximately 7-10 days with anaemia   43
and thrombocytopenia lasting longer than the reduction in the white blood 
cell count. The hematological changes are consistent with what has 
previously been described for the disease in horses in California (Gribble 
1969, Madigan 1993). 
It is not known whether intravenous experimental infection directly 
mimics natural infection especially regarding temporal changes of signs and 
development of serotiters to Anaplasma. The intravenous and tick induced 
experimental infection routes with the HGE-agent in horses have been 
compared (Pusterla et al. 1999a) where a longer incubation period was 
found in tick-induced infection compared to intravenous infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Body temperature (y-axis, ˚C), PCR-signal (blue bar) and visible inclusions (pink bar) in 
neutrophils in peripheral blood in five horses inoculated with A. phagocytophilum. The figure shows
the measurements from day 0 to 21 p.i., through the acute EGA-infection.    44
However the severity of clinical signs, the course of disease and the 
serotiter 30 days after infection was similar regardless of infection route. 
Further, using real-time Taqman-PCR for quantitative analysis of the 
anaplasma burden in the analyzed peripheral blood, there were significantly 
higher bacterial loads noted in the intravenously infected horses in the first 
days after inoculation, whereas the mean anaplasmal load in the later part 
from day 7 to day 9 was significantly higher in the tick-infected group. That 
study concluded similar severity in experimental i.v. infection and 
experimental tick infection (Pusterla et al. 1999a). Whether this holds true 
also for natural tick infection is not known but the results indicate that it 
may indeed be the case. 
The horses in this study (Paper II) seroconverted by day 12-16 p.i. 
which was 6-8 days after onset of clinical signs. At the point of detection of 
seroconversion all horses still had positive PCR, all had still inclusions and 
two of the five were still febrile. Three of five horses had the peak in titer 
while still showing inclusions. The high and uniform anaplasmal dose may 
have influenced the timing of the serologic reaction, which was very similar 
in all these horses.  
A ≥ fourfold rise in titer has been suggested as one way for defining a 
definite diagnosis (Madigan et al. 1990). However, if the change in serotiter 
after clinical signs occurs as fast in naturally infected horses as in the 
experimentally infected horses in this thesis, the first of paired samples needs 
to be taken early in the disease for detection of titerchange. In the above 
cited comparison between i.v. and tick experimental infection (Pusterla et 
al. 1999a) seroconversion occurred significantly later in the tick infested 
group when counting from day of inoculation. When comparing from 
when clinical signs appeared there was no difference in time for 
seroconversion. Moreover, the 30 day convalescent titer was similar in both 
groups.  
In another report (Reubel et al. 1998) three horses were experimentally 
infected via infected ticks. In two out of three horses seroconversion was 
detected 4 and 7 days into clinical disease respectively (the third horse did 
not develop clinical signs of disease and did not seroconvert despite positive 
PCR in blood). In a study on kinematics of antibody after natural infection 
Artursson et al. (1999) found 44% of 25 horses to be seropositive in the 
acute bactaeremic stage of disease after natural infection and 3 out of 10 
horses had reached maximal or next to maximal titer already at the first 
occasion of blood sampling in the acute illness and with inclusions present.  
Combining these various other studies and our findings supports the 
suggestion that, to avoid missing the diagnosis in a paired sampling for   45
detection of a fourfold titer rise, the first sample must be taken early in the 
clinical course. An additional limitation for use of serology as the sole 
diagnostic tool is the high prevalence of seropositivity in horses where EGA 
is endemic despite absence of history of clinical disease.  
  Death due to A. phagocytophilum (Paper III) 
Unexpectedly, one of the 6 experimentally infected horses died suddenly 
two days after onset of clinical signs, at 8 days p.i. The clinical course and 
severity of clinical signs did not differ from the rest of the horses until the 
death occurred. Fatalities in association with A. phagocytophilum infection 
have rarely been reported in the horse. Serious sequelae that may potentially 
be fatal, such as secondary infections or trauma related to ataxia or 
staggering, caused by the acute illness have been reported. However, 
fatalities due to sequelae appear to be uncommon (Gribble 1969, Gribble 
1970, Madigan 1993, Madigan and Pusterla 2000). To the best of our 
knowledge, this report was the first description of a case of equine 
granulocytic anaplasmosis where death was most likely attributed solely to 
A. phagocytophilum infection.  
The pathological macroscopic findings in this horse included 
haemorrhage and edema in the limbs, ventral abdominal wall and prepuce as 
well as in the thoracic and abdominal organs including lungs and kidneys. 
This is in accordance with what is previously described in the pioneering 
work by Gribble (1969 and 1970) on the pathology of this disease in horses 
with the exception that cases in Gribble’s studies lacked extended 
hemorrhage and vasculitis in internal thoracic and abdominal organs. 
Gribble euthanized the horses in different stages of the acute clinical disease 
and described the changes seen. In our horse, because the horse actually 
died, the infection was probably more severe and it is therefore not 
surprising that the same type of changes were more pronounced or more 
widely distributed in this case.  
Microscopically the pathological changes appeared as perivascular and/or 
interstitial infiltrations of mononuclear cells in several organs including lung, 
kidney and liver. The type of changes were similar to those described by 
Gribble (1969, Gribble 1970) and later reexamined by Lepidi et al. (2000). 
The most prominent microscopic lesions in this horse were found in the 
kidneys with necrotising inflammation in the walls of scattered arterioles 
and capillaries. Further, there were swelling of the glomeruli and numerous 
intraluminal hyaline thrombi or globules within the arterioles and capillaries 
This is suggestive of disseminative intravascular coagulation (DIC) which 
may partly explain the fatality. Although uncommon, consumptive   46
coagulopathy and DIC may occasionally occur both in human granulocytic 
anaplasmosis and in human monocytic ehrlichiosis (Bakken et al. 1994, Behl 
et al. 2000). 
Immunohistochemically, the high-titre horse serum labelled occasional 
cells (presumably neutrophils) within the lumen of vessels in the kidneys 
and liver, and within the hepatic sinusoids (Figure 6). Parenchymal cells 
showed no immuno-reactivity. The direct cause of death in the present 
horse was most likely circulatory shock. Negative bacterial cultures, as well 
as the absence of morphological evidence ruled out secondary bacterial 
infections in this case.  
 
 
 
 
 
 
 
 
 
 
Figure 6. Two leukocytes containing A. phagocytophilum antigen (arrows) within the hepatic sinusoids. 
Immunohistochemistry with primary horse serum and AP-conjugated secondary antibody, NBT/BCIP 
as chromogen and light green as counterstain. x 400.  
The reason for that the infection attained such a fulminant course in this 
particular horse is not clear. In EGA experimental infections in horses, 
where the infective doses have been clearly defined, doses used have ranged 
from 1 x10
6 to 4.5x10
7 infected neutrophils (Table 3). In this fatal case, the 
dose was approximately 2 x 10
7 infected cells. This dose was selected based 
on previous experiences with a similar dose (Franzén et al. 1998). In the 
earlier study, the horse developed clinical EGE and recovered uneventfully 
(Franzén et al. 1998). Apart from shorter incubation period, the other horse 
in the present series of 6 infected horses that was also given this higher 
infective dose did not differ clinically when compared to horses with a 
lower infective dose (Paper II). Thus, it is unlikely that the infective dose 
alone was the reason for the fatality. However, for the rest of the horses the 
infection dose was reduced to 6 x10
6 infected cells. Although uncommon, 
fatal cases of infection with A. phagocytophilum also occurs in sheep (Stuen et 
al. 2003). 
   47
Bakken and Dumler (2000) estimated the fatality rate in humans to be 
less then 1% based on previously reported studies (Bakken et al. 1994, 
Aguero-Rosenfeld et al. 1996, Bakken et al. 1996, Dumler and Bakken 
1998, Wallace et al. 1998) and their own clinical experience, and with a 
clear increased risk for mortality in elderly people which is consistent with 
other reports (Olano and Walker 2002). Of four fatalities in man reported 
by Lepidi, three were over 70 years old (Lepidi et al. 2000).  
Although 19 years old, our horse was in good physical condition and 
showed no overt signs of any other disease. However, it cannot be ruled 
out that failure to limit the infection and hence the development of DIC 
was at least partly due to an age-related decreased immunocompetence. In 
acute and sudden death cases of horses, for example on pasture, in areas 
where A.  phagocytophilum is endemic it is suggested that EGA should be 
included in the list of possible differential diagnosis.  
Sudden death due to EGA have been discussed among clinicians 
although not proven. In a recent case a horse was found acutely recumbent 
on pasture, unwilling to stand with no previous known trauma or signs of 
colic noticed. Fever (41.5ºC), staggering movements, heavy breathing and a 
pulse of 50 beats per minute were the main findings at examination. Despite 
initial treatment with oxytetracyclines, i.v.-fluids- and an NSAID, the horse 
died a few hours later. Labratory data verified a positive PCR signal in 
blood and inclusions in 5% of neutrophils. Unfortunately no post mortem 
was performed to verify or reject the suspicion of EGA as the course of 
death.   
 
Convalescent phase (Paper IV)  
Clinical signs  
After acute clinical signs had disappeared in the horses experimentally 
infected, no significant clinical signs were detectable in the horses during 
the follow-up period, apart from some transient subtle clinical changes such 
as mild nasal serous discharge or mild coughing on sporadic days. Mild distal 
limb swelling was found occasionally in the mornings. This can be expected 
as part of normal clinical variation in horses being thoroughly examined
daily for extended time periods. One horse developed thrombo-
phlebitis and in one instance embolic pneumonia occurred, of which
both most probably were iatrogenic and coupled to the long-term 
catheterization of the animals and not to the EGA-infection. Based on 
extended clinical experience, it is likely catheter-related complications may   48
eventually occur in any situation with long-term iv-catheterised horses 
(Gulick and Meagher 1981, Bayly and Vale 1982, Lankveld et al. 2001).  
It has been known for long and is well demonstrated that infection with 
A. phagocytophilum can predispose for secondary infection in sheep and 
enhanced infection susceptibility is also mentioned frequently in the human 
literature. This is not thoroughly documented in the horse apart from some 
cases in Gribble’s series of experimental infections (1970).  
PCR and inclusions in blood  
The results of all PCR samples in blood are shown in Figure 7. From days 
22 (when all signs of acute disease had disappeared) and onward during the 
following months three of five horses were sporadically PCR-positive.  
Further on, after horses were subjected to stress interventions, periodic 
PCR positivity was observed occasionally in some of the horses. After 
dexamethasone administration on days 73-75, horse 1 turned PCR-positive 
for four consecutive days (days 76-79), and horse 5 was positive on day 4-5 
and 12 after challenge (days 102-103, 110) whereas horses 2-4 remained 
negative on PCR after dexamethasone challenges. After transport 
intervention both horse 3 and 4 turned positive for four days one week 
after transport. Stress events in the form of treadmill exercise and rectal 
palpation was not followed by PCR-positivity. In one horse (2) the 
bacterium appear to have been cleared after day 33 p.i. whereas in the other 
four horses the last days of PCR-positivity were days 70, 79, 110 and 129 
for individual horses (day 129 also being the last day of the trial). 
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Figure 7. PCR results in blood from five horses during ~4 months after i.v. inoculation (day 0) with 
A. phagocytophilum. Positive/negative bars indicates positive/negative PCR signal. Black arrow 
indicates a three-day dexamethazone treatment, white arrow indicates a four-hour trailer transportation, 
grey arrow indicates repeated treadmill exercise.   
 
Once the acute disease phase had resolved inclusions in neutrophils were 
not observed at any of the sampling occasions, including when the PCR 
signal was positive. Sheep can be PCR-postive and show inclusions in 
neutrophils when persistently infected (Stuen et al. 2001a, Stuen and 
Bergström 2001b, Stuen et al. 1998b). Two experimentally infected dogs 
in the convalescence phase, when given corticoids three and five months 
p.i. respectively turned PCR-positive and at a few occasions inclusions were 
also detected (Egenvall et al. 2000a) several months p.i., the latter contrary 
to the horses in this study. This suggests that horses may be less prone than 
sheep and dogs to develop inclusions after the acute stage of febrile disease, 
despite the agent still apparently being present in the body. The PCR signal 
became positive only intermittently after corticosteroid challenge and was   50
also only intermittently positive on other occasions. This could be due to 
the number of bacteria in peripheral blood being intermittently under (or 
above) the detection level of the PCR used (one mL of EDTA blood was 
used for each DNA extraction). Since the cell reservoir of the bacteria is not 
known, it is possible that shedding into the peripheral blood is intermittent 
(given that the reservoir is not the circulating neutrophils themselves).  
 
Post mortem findings 
The catheter-related complications noted clinically were confirmed as 
jugular vein thrombophlebitis and embolic staphylococcal pneumonia post 
mortem. Further, four of five horses had mild to moderate degenerative 
joint lesions characterized by linear grooving and small erosions of the 
articular cartilage in the fetlock joint of three horses, elbow joint of two 
horses and in the hock joint of one horse. Taking into account that four of 
five horses had long-lasting (and successful) histories as racehorses and the 
fifth horse had been used as a riding-school horse for more than 12 years, 
such joint lesions can be expected.   
Microscopically, mild perivascular infiltration of mononuclear 
inflammatory cells was sporadically observed in lung, live portal tracts, 
kidney and joint capsule in selected horses. Similar discrete, nonspecific 
mild infiltrates of small numbers of mononuclear cells are often seen in adult 
horses, whether healthy or diseased, when performing such a thorough post 
mortem examination. Accordingly, association of these changes to the 
possible persistence of A. phagocytophilum can neither be definitely included 
or excluded.  
The absence of specific post mortem changes is in accordance with 
results reported from long term follow-up of experimental infection in dogs 
with the same agent where molecular evidence for persistent infection in 
blood was demonstrated (Egenvall et al. 2000a). Routine bacteriology from 
internal organs of the horses was negative in all instances apart from the 
staphylococccal pneumonia as described above.  
All tissue samples in all horses proved negative for A. phagocytophilum by 
PCR. As immunochemistry is less sensitive than PCR for identification of 
the bacterium and as all tissues were PCR-negative, immunochemistry was 
not performed.   
Experimental infection versus natural infection 
This was an i.v. inoculation study. However, according to the literature it is 
probably safe to assume that the difference between i.v. inoculation and   51
tick-borne infection is limited (Pusterla et al. 1999a). There are both 
strengths and weaknesses with experimental infections. A possible limitation 
is that rapid i.v. inoculation does not mimic natural tick bites, where the 
infection likely is transferred over time. Further, it is likely that the i.v. 
infection dose is much higher in experimental infection. The intravenous 
infection route has been compared to the tick infection route in an 
experimental infection with the HGE-agent to horses (Pusterla et al. 
1999a). The i.v. route had shorter incubation time and shorter time to 
seroconversion.  
However, once clinical signs had appeared, the course of clinical disease 
was similar in both groups. This is also consistent with the course of events 
observed after experimentally induced Anaplasma infection with 
horsederived isolates and similar to natural infection (Gribble 1969, 
Madigan and Gribble 1987). Surprisingly the tick infected group had a 
higher total bacterial load and a longer bacteraemia as evaluated by real-time 
quantitative PCR. Nonetheless, the study was an experimental tick 
infection which is not likely identical in all aspects to natural tick infection.  
It is further not known if natural infection is comparable to experimental 
i.v. infection with respect to persistence of bacteremia. However, these 
observations suggest that if there are biological differences between i.v. 
inoculation and tick infestation-infection they may be small. One strength 
with experimental infection, compared to following clinical cases, is that it 
is much simpler to have predefined sampling intervals, and follow 
parameters and changes longitudinally, as timing of infection is predefined 
and the animals are available for sampling over the entire course of 
infection. It could be considered a weakness that the study not included 
control horses. This was due mainly to economic reasons and also ethical 
reasons.  
The question of persistent Anaplasma infection and “chronic” disease 
This study, on a few experimentally infected horses, found evidence for the 
persistence of the A. phagocytophilum organism for up to four months in the 
blood may occur in horses recovering from acute EGA. However, no 
evidence was found to support the existence of clinically detectable 
“chronic” form of disease meaning persistence of infection together with 
clinical manifestations. After the acute phase with typical clinical signs of 
EGA-disease no further signs of illness were found connected to the 
infection in any of the horses despite thorough daily complete examination. 
 No specific findings were noted on post mortem in any of the horses, 
nor were there any PCR positives in the tested organs from the horses.   52
When comparing with other species these results are in accordance with 
what is shown in experimentally infected dogs. Persistence of A. 
phagocytophilum in blood, shown as a positive PCR-signal, was shown up to 
6 months without detectable clinical signs, bearing in mind the long term 
follow-up included only three dogs (Egenvall et al. 2000a). Alleman et al. 
(2006) experimentally infected two dogs with a human isolate. The authors 
found persistence (via PCR) of infection up to 340 days p.i. during 
intermittent periods following heavy corticosteroid medication, however in 
the abscense of clinical signs during the whole year follow up.  
In contrast, in ruminants and especially lambs persistent infection appears 
to be common and with documented increased risk for secondary infection 
and persistent infection in lambs has also been associated with reduced 
weight gain. The effect of chronic infection and secondary problems in 
lambs due to A. phagocytophilum infection has been known for long and is 
well documented.  
The potential for chronicity in humans with HGE have been mentioned 
(Dumler and Bakken 1996) but the same authors later stated that “there is 
currently no clinical evidence in the literature that untreated HGE may 
evolve into a chronic illness as have been seen with Lyme Borrelia”. They 
further stated that “persistently elevated antibody titers should therefore be 
interpreted as evidence of post infection rather than as proof for ongoing 
unresolved infectious process”, and that “unlike Lyme borreliosis there does 
not appear to be a chronic form of HGE” (Bakken and Dumler 2000).  
This is in accordance with a study where no clinical abnormalities were 
found in a long term follow-up of 30 patients diagnosed with HGE, 
whereas patients who had had additional tick bites after primary infection 
had significantly higher antibody titers in the follow up 24 month period 
(Lotric-Furlan et al. 2001).  
A report on antibiotic-treated HGE-patients on average 2 years after 
onset of illness had lower health status scores for bodily pain and health 
relative to one year earlier documented via retrospective telephone-
interviews and statistical preparation of the answers.  However, there was 
no significant difference in physical functioning, general health or vitality 
measures as compared to controls (Ramsey et al. 2002).  
In the discussion of possible persistence causing clinical disease in horses 
there is anecdotal experience by veterinarians suggesting improvement of 
health of horses after treatment with oxytetracyclines, which has been 
interpreted that Anaplasma-infection was present in these horses. While this 
may be true, it is no proof for that A. phagocytophilum was present or that 
signs were caused by this infection. One reason for this is that   53
oxytetracycline is a broad-spectrum antibiotic with a wide range of 
microorganisms being sensitive.  
Further, tetracyclines have several pharmacological effects other than the 
antimicrobial effect (Sapadin and Fleischmajer 2006), such as anti-
inflammatory effects probably mediated through inhibiting matrix 
metalloproteinases ( Ramamurthy et al. 2002, Vidal et al. 2007) and are 
currently under study for the treatment of osteoarthritis (Vidal et al. 2007). 
Doxycycline, another tetracycline antibiotic, has been shown to reduce 
severity of cartilage lesions in dogs with osteoarthritis (Hanemaaijer et al. 
2001) as well as have positive clinical effect in humans with knee 
osteoarthritis (Brandt et al. 2003a, Brandt et al. 2003b). Other non-
antibiotic use of tetracyclines includes treatment of rhematoid arthritis and 
rosacea  in humans (Voils et al. 2005) and treatment of contracted tendons 
in foals (Lokai and Meyer 1985). 
 
 In conclusion, this study showed molecular evidence for persistence of 
the A. phagocytophilum organism for up to three months in the blood of 
horses after recovery from acute EGA, but found no evidence to support 
persistence together with clinical manifestations of disease. After the acute 
phase with typical clinical signs of EGA-disease no further signs of illness 
were found that could be connected to the infection in any of the horses, 
despite daily complete examination. Neither were specific findings noted in 
any of the horses on post mortem, nor were the PCR test positive in any 
tested organ from the horses.    54
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  Summary and conclusions  
 
•  The overall seroprevalence of antibodies to A. phagocytophilum, as 
determined from a population of horses visiting equine clinics in all 
parts of Sweden was 16.6% with large differences dependent on 
geographic location within the country. 
•  In this population there was no statistically significant correlation 
between seropositivity and any disease parameter or diagnosis 
recorded.  
•  In the healthy group of horses the seroprevalence of antibodies to 
A. phagocytophilum did not significantly differ from that in the group 
of horses with clinical signs.  
•  PCR is a more sensitive diagnostic tool than inclusions in the early 
phase of clinical disease.  
•  Death due to equine granulocytic anaplasmosis may occur and 
should possibly be included as a differential diagnosis in conjunction 
with cases of acute death on pasture in endemic areas.  
•  Molecular proof for persistence A. phagocytophilum for up to four 
months after experimental infection was demonstrated in certain 
individuals. 
•  The persistence of A. phagocytophilum was not coupled to any 
detectable clinical signs of disease or any specific pathological 
changes at post mortem.  
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